Trials / Conditions / Alcoholic Cirrhosis

Alcoholic Cirrhosis

21 registered clinical trials studyying Alcoholic Cirrhosis — 5 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Optimized Remission in Alcohol-related Liver Cirrhosis NCT06866496	Copenhagen University Hospital, Hvidovre	N/A
Withdrawn	Early Detection of Alcoholic Liver Disease NCT04070508	University of Pittsburgh	—
Enrolling By Invitation	Safety & Efficacy of Baclofen for Alcohol Withdrawal in Chronic Liver Disease With Active Alcohol Consumption NCT06840652	Corporacion Parc Tauli	—
Unknown	Study of Decompensated Alcoholic Cirrhosis Treatment by Stem Cells NCT05155657	Yantai Yuhuangding Hospital	Phase 1
Recruiting	Long-term Follow-up of Patients With Alcoholic Liver Cirrhosis Who Had Administered Cellgram-LC in PMC-P-07 St NCT05093881	Pharmicell Co., Ltd.	N/A
Recruiting	Clinical Trial to Evaluate the Efficacy and Safety of Cellgram-LC Administration in Patients With Alcoholic Ci NCT04689152	Pharmicell Co., Ltd.	Phase 3
Unknown	EUS Based Prevalence of Chronic Pancreatitis in Alcoholic Cirrhosis NCT04245189	Asian Institute of Gastroenterology, India	—
Recruiting	SAMe Trial for Patients With Alcoholic Cirrhosis NCT04250259	Indiana University	Phase 2
Unknown	Alcohol Biomarker Study NCT04363424	Maastricht University Medical Center	—
Unknown	Study of Genetic Determinants in Alcoholic Hepatitis and Establishment of a Multicenter Prospective Cohort of NCT04106518	University Hospital, Lille	—
Terminated	Mild Hypothermia and Acute Kidney Injury in Liver Transplantation NCT03534141	University of California, San Francisco	N/A
Terminated	Value on Survival of Liver Volume After an Acute Decompensation of an Alcoholic Cirrhosis NCT03508388	University Hospital, Montpellier	—
Completed	Randomised Open-label Multicenter Study Evaluating Ciprofloxacin in Severe Alcoholic Hepatitis NCT02326103	University of Helsinki	EARLY_Phase 1
Completed	Validation of the Procedure of Early Liver Transplantation in Alcoholic Hepatitis Resisting to Medical Treatme NCT01756794	University Hospital, Lille	N/A
Terminated	Phlebotomy and Risk of Hepatocellular Carcinoma in Patients With Compensated Alcoholic Cirrhosis NCT01342705	Assistance Publique - Hôpitaux de Paris	Phase 3
Unknown	National Cohort of Uncomplicated Alcoholic Cirrhosis NCT01213927	Assistance Publique - Hôpitaux de Paris	—
Completed	Zinc Supplementation in Alcoholic Cirrhosis NCT02072746	University of Louisville	N/A
Completed	Indocyanine Green and Portal Pressure in Viral and Alcoholic Cirrhotic Patients With Hepatocarcinoma NCT00827723	University of Lausanne Hospitals	—
Completed	Pangenomic Study During Alcoholic Cirrhosis NCT01065233	Nantes University Hospital	—
Completed	Adipose Tissue Involvement in Alcohol-induced Liver Inflammation in Human NCT00388323	Assistance Publique - Hôpitaux de Paris	N/A
Terminated	Hemodynamic Effects of Chronic Administration of Spironolactone and/or Propranolol in Alcoholic Cirrhotic Pati NCT00188045	University Hospital, Angers	Phase 4